<?xml version="1.0"?>
<metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:title>Zdravilo durvalumab za zdravljenje raka pljuč</dc:title><dc:creator>Vrankar,	Martina	(Avtor)
	</dc:creator><dc:creator>Unk,	Mojca	(Recenzent)
	</dc:creator><dc:subject>rak pljuč</dc:subject><dc:subject>kemoterapija</dc:subject><dc:subject>durvalumab</dc:subject><dc:publisher>Onkološki inštitut</dc:publisher><dc:date>2018</dc:date><dc:date>2025-09-03 14:03:23</dc:date><dc:type>Neznano</dc:type><dc:identifier>23476</dc:identifier><dc:identifier>UDK: 616.2</dc:identifier><dc:identifier>COBISS_ID: 114086147</dc:identifier><dc:source>Ljubljana</dc:source><dc:language>sl</dc:language></metadata>
